From: Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Blood parameter
Cut-off value
irAEs, n (%)
PÂ value
NLRÂ post
4.5
0.001*
Low(n=Â 331)
120/331Â (36.3%)
High(n = 87)
56/87Â (64.4%)
CTC
15.0 FU/ml
<0.001*
Low(n=Â 41)
13/41Â (31.7%)
High(n = 30)
16/30Â (53.3%)